CIK 0000310158
- Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221918501
- Phone
- +1 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale EVP, Chief HR Officer sold 53,400 shares at an average $119.01 ($6,355,056)
- 4 Open-market sale EVP, General Counsel sold 19,141 shares at $117.59 ($2,250,834)
- 4 Exercise or conversion President, U.S. Market acquired 907 shares (option exercise)
- 4 Exercise or conversion EVP - Chief Strategy Officer acquired 885 shares (option exercise)
- 4 Exercise or conversion SVP Chief Ethics & Com Officer acquired 1,502 shares (option exercise)
- 4 Open-market sale Sr. VP Fince-Global Controller sold 15,875 shares at $117.53 ($1,865,843)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 13 of 99 · 1,973 filings